Company Overview of NGM Biopharmaceuticals, Inc.
Key Executives for NGM Biopharmaceuticals, Inc.
|William J. Rieflin||11 Relationships||Chief Executive Officer and Director||56|
|Jeffrey D. Jonker J.D.||No Relationships||President||43|
|Jin-Long Chen Ph.D.||11 Relationships||Founder, Chief Scientific Officer and Director||53|
|David Woodhouse Ph.D.||No Relationships||Chief Financial Officer||--|
|Aetna Wun Trombley Ph.D.||4 Relationships||Chief Operating Officer and Vice President||--|
|View More Key Executives|
NGM Biopharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|David V. Goeddel Ph.D.||66 Relationships||Igenica, Inc.||64|
|William J. Rieflin||11 Relationships||NGM Biopharmaceuticals, Inc.||56|
|Jin-Long Chen Ph.D.||11 Relationships||NGM Biopharmaceuticals, Inc.||53|
|Michael S. Brown M.D.||34 Relationships||Peloton Therapeutics, Inc.||75|
|McHenry T. Tichenor Jr.||11 Relationships||Tichenor Ventures, LLC||60|
NGM Biopharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D.||Michael S. Brown||34 Relationships||5 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.